2021
DOI: 10.1016/j.ajic.2020.08.018
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 8 publications
1
4
0
Order By: Relevance
“…The predominance of MBL was also reported by Bitar et al [28]. O'Neall et al reported that VIM was the most predominant (20.8 %) in their isolates while NDM was detected only in 2.8 % [23].…”
Section: Novaissupporting
confidence: 70%
See 1 more Smart Citation
“…The predominance of MBL was also reported by Bitar et al [28]. O'Neall et al reported that VIM was the most predominant (20.8 %) in their isolates while NDM was detected only in 2.8 % [23].…”
Section: Novaissupporting
confidence: 70%
“…Carbapenemase production can be detected in the laboratory by many phenotypic and genotypic methods. Among the phenotypic methods the Carba Blue test has been evaluated and found to be both rapid, accurate and cost-effective [23]. However, the test may give false negative result with week or lowlevel carbapenemase production, especially with metallo-beta lactamases (MBL) [24].…”
Section: Detection Of Carbapenemasesmentioning
confidence: 99%
“…5,6 Concordantly, we have shown the importance of an early BCT result when applied in infections caused by Pseudomonas aeruginosa isolates. 7 For the infection control point of view, in our study, for 25 patients (16%) and 121 patients (78%) anticipated the installation of standard and contact precaution, respectively, based on an early BCT notification. On the other hand, from a clinical point of view, this fact means that an active antimicrobial agent (mostly polymyxin B in our study) should be initiated or included for adequacy of therapy.…”
mentioning
confidence: 73%
“…The methodological quality of six diagnostic accuracy studies was assessed by the QUADAS-2 guideline. Five studies were of high quality with scores ranging from 13 to 17 points [ 24 28 ], while one study was of medium quality (11 points) [ 23 ].…”
Section: Resultsmentioning
confidence: 99%